Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03561259 |
|---|---|
| Brief Title: | A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects (OPTIMUM) |
| First Submitted : | June 7, 2018 |
| First Submitted that Met QC Criteria : | June 7, 2018 |
| First Posted : | June 19, 2018 |
| Last Update Submitted that Met QC Criteria : | February 15, 2023 |
| Last Update Posted : | February 16, 2023 |